​

Apogee Therapeutics Ownership | Who Owns Apogee Therapeutics?

OverviewForecastFinancialsChart

Apogee Therapeutics Ownership Summary

Apogee Therapeutics is owned by 124.04% institutional investors, 7.63% insiders. Aigen investment management, lp is the largest institutional shareholder, holding 0% of APGE shares.

APGE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockApogee Therapeutics124.04%7.63%-31.67%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aigen investment management, lp---
Parallel advisors---
Smartleaf asset management---
Verition fund management---
Allianz asset management gmbh---
Simplex trading---
Candriam s.c.a.---
Schonfeld strategic advisors---
Readystate asset management lp---
Logos global management lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigen investment management, lp---
Parallel advisors---
Smartleaf asset management---
Verition fund management---
Allianz asset management gmbh---
Simplex trading---
Candriam s.c.a.---
Schonfeld strategic advisors---
Readystate asset management lp---
Logos global management lp---

Top Buyers

HolderShares% AssetsChange
Parallel advisors---6.00
Simplex trading---73.00
Smartleaf asset management---82.00
Virtus etf advisers---1.60K
Aigen investment management, lp---4.77K

Top Sellers

HolderShares% AssetsChange
Logos global management lp---300.00K
Cubist systematic strategies---91.21K
Candriam s.c.a.---85.66K
Schonfeld strategic advisors---70.77K
Ensign peak advisors---69.75K

Sold Out

HolderChange
Parallel advisors-6.00
Simplex trading-73.00
Smartleaf asset management-82.00
Virtus etf advisers-1.60K
Aigen investment management, lp-4.77K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202517811.25%72,188,05328.01%1241.19%85-10.53%5955.26%
Dec 31, 202416210.96%57,868,2753.16%1041.07%9729.33%38-17.39%
Sep 30, 20241464.29%56,094,4303.58%981.08%75-7.41%4612.20%
Jun 30, 2024140-54,153,5852.36%950.86%81-28.32%41115.79%
Mar 31, 202414064.71%52,903,02526.66%1051.55%113109.26%19111.11%

Recent Insider Transactions

DateNameRoleActivityValue
Jun 04, 2025Dambkowski Carl Chief Medical OfficerSell$100.72K
May 07, 2025Dambkowski Carl Chief Medical OfficerSell$97.42K
Apr 02, 2025Dambkowski Carl Chief Medical OfficerSell$18.52K
Apr 02, 2025Dambkowski Carl Chief Medical OfficerSell$87.87K
Apr 02, 2025Dambkowski Carl Chief Medical OfficerSell$33.42K

Insider Transactions Trends

DateBuySell
2025 Q2-5
2025 Q1-10
2024 Q4213
2024 Q3-11
2024 Q1--

APGE Ownership FAQ

Who Owns Apogee Therapeutics?

Apogee Therapeutics shareholders are primarily institutional investors at 124.04%, followed by 7.63% insiders and -31.67% retail investors. The average institutional ownership in Apogee Therapeutics's industry, Biotech Stocks , is 63.97%, which Apogee Therapeutics exceeds.

Who owns the most shares of Apogee Therapeutics?

Apogee Therapeutics’s largest shareholders are Aigen investment management, lp (0 shares, 0%), Parallel advisors (0 shares, 0%), and Smartleaf asset management (0 shares, 0%). Together, they hold 0% of Apogee Therapeutics’s total shares outstanding.

Does Blackrock own Apogee Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Apogee Therapeutics.

Who is Apogee Therapeutics’s biggest shareholder by percentage of total assets invested?

Aigen investment management, lp is Apogee Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Apogee Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools